Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
| Cat.No. | Product Name | Price |
|---|---|---|
| CSC-DC004105 | Panoply™ Human DCTPP1 Knockdown Stable Cell Line | Inquiry |
| CSC-SC004105 | Panoply™ Human DCTPP1 Over-expressing Stable Cell Line | Inquiry |
| CLKO-0852 | DCTPP1 KO Cell Lysate-HEK293T | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| AD04659Z | Human DCTPP1 adenoviral particles | Inquiry |
| LV10428L | human DCTPP1 (NM_024096) lentivirus particles | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| SHH275429 | shRNA set against Human DCTPP1 (NM_024096.1) | Inquiry |
| SHH275433 | shRNA set against Mouse DCTPP1 (NM_023203.1) | Inquiry |
| SHH275437 | shRNA set against Rat DCTPP1 (NM_138892.1) | Inquiry |
| Cat.No. | Product Name | Price |
|---|---|---|
| CDFG004248 | Human DCTPP1 cDNA Clone(NM_024096.1) | Inquiry |
| CDFR014316 | Rat Dctpp1 cDNA Clone(NM_138892.1) | Inquiry |
| MiUTR1H-11327 | DCTPP1 miRNA 3'UTR clone | Inquiry |
| MiUTR1M-00417 | DCTPP1 miRNA 3'UTR clone | Inquiry |
| MiUTR1R-07099 | DCTPP1 miRNA 3'UTR clone | Inquiry |
| SKO0425 | DCTPP1 Validated sgRNA vector | Inquiry |
| CDCB159008 | Human DCTPP1 ORF clone (BC001344) | Inquiry |
| CDCB183611 | Rabbit DCTPP1 ORF clone (XM_002721764.2) | Inquiry |
| CDCR054100 | Human DCTPP1 ORF clone (NM_024096.1) | Inquiry |
| CDCR381363 | Rat Dctpp1 ORF Clone(NM_138892.1) | Inquiry |
| CDCS415667 | Human DCTPP1 ORF Clone (BC001344) | Inquiry |
The deoxycytidine triphosphatase pyrophosphatase 1 (Dctpp1) gene is a crucial enzyme involved in various cellular processes, including nucleotide metabolism, DNA replication, and cell signaling. The Dctpp1 enzyme is highly conserved across various species, indicating its essential role in biological processes.
The Dctpp1 gene encodes for an enzyme that belongs to the pyrophosphatase family, which is responsible for removing the terminal pyrophosphate group from various nucleotides. In particular, Dctpp1 is known to hydrolyze deoxycytidine triphosphate (dCTP) to deoxycytidine monophosphate (dCMP) and inorganic pyrophosphate. The structure of Dctpp1 enzyme has been identified, which reveals a classic Rossmann-fold domain and a catalytic center containing a highly conserved Asp-Glu-His-Asp (DEHD) motif. This motif is responsible for binding the substrate and facilitating the hydrolysis reaction.
The function of Dctpp1 is to regulate the cellular levels of deoxyribonucleotides, which are essential for DNA replication and repair. The hydrolysis of dCTP to dCMP by Dctpp1 plays a significant role in the control of DNA synthesis, as dCMP is a poor substrate for DNA polymerases. Moreover, Dctpp1 has been shown to regulate the levels of deoxyuridine monophosphate (dUMP), which is an essential precursor for the synthesis of thymidine, a component of DNA.
The expression of Dctpp1 is regulated at multiple levels, including transcription, translation, and post-translational modification. Transcriptional regulation of Dctpp1 has been reported to be influenced by various transcription factors and chromatin remodeling complexes. For instance, the activity of Dctpp1 is upregulated by the transcription factor Sp1, which binds to the promoter region of the Dctpp1 gene. Additionally, Dctpp1 expression can be regulated by RNA processing and degradation, as well as by microRNAs (miRNAs).
Post-translational modifications such as phosphorylation, ubiquitination, and sumoylation also play a significant role in regulating the activity and stability of Dctpp1. Phosphorylation of Dctpp1 at specific sites can modulate its enzymatic activity and cellular localization. For example, the phosphorylation of Dctpp1 at Serine 521 by cyclin-dependent kinase 2 (CDK2) promotes its nuclear localization and enhances its enzymatic activity.
Alterations in the expression and function of Dctpp1 have been associated with various diseases, including cancer, cardiovascular diseases, and neurodegenerative disorders. In cancer, Dctpp1 has been reported to be overexpressed, which contributes to the uncontrolled cell growth and proliferation observed in tumors. Inhibition of Dctpp1 has been shown to inhibit cancer cell growth and to sensitize cells to chemotherapy.
In cardiovascular diseases, Dctpp1 has been implicated in the pathogenesis of atherosclerosis and arrhythmias. For instance, Dctpp1 is upregulated in cardiomyocytes following myocardial infarction, which suggests a role in the remodeling of the heart. In neurodegenerative disorders such as Alzheimer's disease (AD), Dctpp1 has been reported to be downregulated, which may contribute to the abnormal deposition of amyloid-beta (Aβ) plaques observed in AD patients.
References: